Company Description

Esperovax is a private U.S.-based biotechnology company focused on developing next-generation oral RNA vaccine and therapeutic platforms and products. Leveraging proprietary technologies, Esperovax aims to create effective, easy-to-administer vaccines that address unmet medical needs across various infectious diseases and biothreats.